Wells Fargo analyst Stan Berenshteyn lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $13.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE